newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Third Quarter 2021 Financial and Business Results

●Q3 Revenue of $9.5 Million is a 15% Improvement versus Q3 2020 ●Year to Date Revenue of $30.5 Million Up 34% Versus Prior Year ●Second Consecutive Record Cash Collection Quarter ●Significantly Improved Liquidity with Comerica Bank $7.5 Cred